KNOXVILLE, Tenn. & SYDNEY, Australia--(BUSINESS WIRE)--Provectus Pharmaceuticals (OTC BB: PVCT) and the Australia and New Zealand Melanoma Trials Group (ANZMTG) have joined forces to advance cutting edge melanoma research at the University of Sydney, it was announced today.
